The	O
construction	O
of	O
three	B:C0450363
-	I:C0450363
dimensional	I:C0450363
composite	O
fibrous	O
macrostructures	O
with	O
nanotextures	O
for	O
biomedical	O
applications	O
.	O

The	O
construction	O
of	O
three	O
-	I:C0450363
dimensional	I:C0450363
composite	B:C0009570
fibrous	O
macrostructures	O
with	O
nanotextures	O
for	O
biomedical	O
applications	O
.	O

The	O
construction	O
of	O
three	O
-	I:C0450363
dimensional	I:C0450363
composite	O
fibrous	O
macrostructures	B:C0678594
with	O
nanotextures	O
for	O
biomedical	O
applications	O
.	O

The	O
construction	O
of	O
three	O
-	I:C0450363
dimensional	I:C0450363
composite	O
fibrous	O
macrostructures	O
with	O
nanotextures	O
for	O
biomedical	B:C1879848
applications	O
.	O

The	O
development	O
of	O
modern	O
biomedical	B:C1879848
nanotechnology	O
requires	O
three	O
-	I:C0450363
dimensional	I:C0450363
macrostructures	O
with	O
nanotextures	O
to	O
meet	O
the	O
requirements	O
for	O
practical	O
applications	O
in	O
intricate	O
biological	O
systems	I:C0460002
.	O

The	O
development	O
of	O
modern	O
biomedical	O
nanotechnology	O
requires	O
three	B:C0450363
-	I:C0450363
dimensional	I:C0450363
macrostructures	O
with	O
nanotextures	O
to	O
meet	O
the	O
requirements	O
for	O
practical	O
applications	O
in	O
intricate	O
biological	O
systems	I:C0460002
.	O

The	O
development	O
of	O
modern	O
biomedical	O
nanotechnology	O
requires	O
three	O
-	I:C0450363
dimensional	I:C0450363
macrostructures	B:C0678594
with	O
nanotextures	O
to	O
meet	O
the	O
requirements	O
for	O
practical	O
applications	O
in	O
intricate	O
biological	O
systems	I:C0460002
.	O

The	O
development	O
of	O
modern	O
biomedical	O
nanotechnology	O
requires	O
three	O
-	I:C0450363
dimensional	I:C0450363
macrostructures	O
with	O
nanotextures	O
to	O
meet	O
the	O
requirements	O
for	O
practical	O
applications	O
in	O
intricate	O
biological	B:C0460002
systems	I:C0460002
.	O

Additionally	O
,	O
the	O
restoration	O
and	O
regeneration	B:C0815081
of	O
some	O
specific	O
body	O
tissues	I:C0040300
and	O
organs	O
rely	O
on	O
the	O
function	O
of	O
conductive	O
polymers	I:C0032521
,	O
which	O
can	O
provide	O
electrical	O
cues	O
for	O
cells	O
.	O

Additionally	O
,	O
the	O
restoration	O
and	O
regeneration	O
of	O
some	O
specific	O
body	B:C0040300
tissues	I:C0040300
and	O
organs	O
rely	O
on	O
the	O
function	O
of	O
conductive	O
polymers	I:C0032521
,	O
which	O
can	O
provide	O
electrical	O
cues	O
for	O
cells	O
.	O

Additionally	O
,	O
the	O
restoration	O
and	O
regeneration	O
of	O
some	O
specific	O
body	O
tissues	I:C0040300
and	O
organs	B:C0178784
rely	O
on	O
the	O
function	O
of	O
conductive	O
polymers	I:C0032521
,	O
which	O
can	O
provide	O
electrical	O
cues	O
for	O
cells	O
.	O

Additionally	O
,	O
the	O
restoration	O
and	O
regeneration	O
of	O
some	O
specific	O
body	O
tissues	I:C0040300
and	O
organs	O
rely	O
on	O
the	O
function	O
of	O
conductive	B:C0032521
polymers	I:C0032521
,	O
which	O
can	O
provide	O
electrical	O
cues	O
for	O
cells	O
.	O

Additionally	O
,	O
the	O
restoration	O
and	O
regeneration	O
of	O
some	O
specific	O
body	O
tissues	I:C0040300
and	O
organs	O
rely	O
on	O
the	O
function	O
of	O
conductive	O
polymers	I:C0032521
,	O
which	O
can	O
provide	O
electrical	O
cues	O
for	O
cells	B:C0007634
.	O

In	O
this	O
study	O
,	O
we	O
fabricated	O
three	B:C0450363
-	I:C0450363
dimensional	I:C0450363
composite	O
nanofibre	O
macrostructures	O
of	O
polycaprolactone	O
(	O
polycaprolactone	O
)	O
with	O
different	O
concentrations	O
of	O
polyaniline	O
(	O
polyaniline	O
)	O
by	O
employing	O
an	O
improved	O
electrospinning	O
technology	O
with	O
a	O
specially	O
designed	O
collector	O
.	O

In	O
this	O
study	O
,	O
we	O
fabricated	O
three	O
-	I:C0450363
dimensional	I:C0450363
composite	B:C0009570
nanofibre	O
macrostructures	O
of	O
polycaprolactone	O
(	O
polycaprolactone	O
)	O
with	O
different	O
concentrations	O
of	O
polyaniline	O
(	O
polyaniline	O
)	O
by	O
employing	O
an	O
improved	O
electrospinning	O
technology	O
with	O
a	O
specially	O
designed	O
collector	O
.	O

In	O
this	O
study	O
,	O
we	O
fabricated	O
three	O
-	I:C0450363
dimensional	I:C0450363
composite	O
nanofibre	O
macrostructures	B:C0678594
of	O
polycaprolactone	O
(	O
polycaprolactone	O
)	O
with	O
different	O
concentrations	O
of	O
polyaniline	O
(	O
polyaniline	O
)	O
by	O
employing	O
an	O
improved	O
electrospinning	O
technology	O
with	O
a	O
specially	O
designed	O
collector	O
.	O

In	O
this	O
study	O
,	O
we	O
fabricated	O
three	O
-	I:C0450363
dimensional	I:C0450363
composite	O
nanofibre	O
macrostructures	O
of	O
polycaprolactone	B:C0137734
(	O
polycaprolactone	O
)	O
with	O
different	O
concentrations	O
of	O
polyaniline	O
(	O
polyaniline	O
)	O
by	O
employing	O
an	O
improved	O
electrospinning	O
technology	O
with	O
a	O
specially	O
designed	O
collector	O
.	O

In	O
this	O
study	O
,	O
we	O
fabricated	O
three	O
-	I:C0450363
dimensional	I:C0450363
composite	O
nanofibre	O
macrostructures	O
of	O
polycaprolactone	O
(	O
polycaprolactone	B:C0137734
)	O
with	O
different	O
concentrations	O
of	O
polyaniline	O
(	O
polyaniline	O
)	O
by	O
employing	O
an	O
improved	O
electrospinning	O
technology	O
with	O
a	O
specially	O
designed	O
collector	O
.	O

In	O
this	O
study	O
,	O
we	O
fabricated	O
three	O
-	I:C0450363
dimensional	I:C0450363
composite	O
nanofibre	O
macrostructures	O
of	O
polycaprolactone	O
(	O
polycaprolactone	O
)	O
with	O
different	O
concentrations	O
of	O
polyaniline	B:C0962453
(	O
polyaniline	O
)	O
by	O
employing	O
an	O
improved	O
electrospinning	O
technology	O
with	O
a	O
specially	O
designed	O
collector	O
.	O

In	O
this	O
study	O
,	O
we	O
fabricated	O
three	O
-	I:C0450363
dimensional	I:C0450363
composite	O
nanofibre	O
macrostructures	O
of	O
polycaprolactone	O
(	O
polycaprolactone	O
)	O
with	O
different	O
concentrations	O
of	O
polyaniline	O
(	O
polyaniline	B:C0962453
)	O
by	O
employing	O
an	O
improved	O
electrospinning	O
technology	O
with	O
a	O
specially	O
designed	O
collector	O
.	O

The	O
3D	B:C0450363
structures	O
possessed	O
cap	O
-	I:C0678594
like	I:C0678594
macrostructures	I:C0678594
with	O
centimetre	O
-	O
scale	O
thickness	O
and	O
interconnected	O
pore	O
nanotextures	O
with	O
nanometre	O
-	O
scale	O
nanofibres	O
.	O

The	O
3D	O
structures	B:C0678594
possessed	O
cap	O
-	I:C0678594
like	I:C0678594
macrostructures	I:C0678594
with	O
centimetre	O
-	O
scale	O
thickness	O
and	O
interconnected	O
pore	O
nanotextures	O
with	O
nanometre	O
-	O
scale	O
nanofibres	O
.	O

The	O
3D	O
structures	O
possessed	O
cap	B:C0678594
-	I:C0678594
like	I:C0678594
macrostructures	I:C0678594
with	O
centimetre	O
-	O
scale	O
thickness	O
and	O
interconnected	O
pore	O
nanotextures	O
with	O
nanometre	O
-	O
scale	O
nanofibres	O
.	O

To	O
estimate	O
the	O
biocompatibility	O
of	O
the	O
3D	B:C0450363
polycaprolactone	O
/	O
polyaniline	O
composite	O
nanofibre	O
macrostructures	O
,	O
mouse	O
myoblasts	O
(	O
C2C12	O
cells	I:C0596995
)	O
were	O
cultured	O
as	O
model	O
cells	O
.	O

To	O
estimate	O
the	O
biocompatibility	O
of	O
the	O
3D	O
polycaprolactone	B:C0137734
/	O
polyaniline	O
composite	O
nanofibre	O
macrostructures	O
,	O
mouse	O
myoblasts	O
(	O
C2C12	O
cells	I:C0596995
)	O
were	O
cultured	O
as	O
model	O
cells	O
.	O

To	O
estimate	O
the	O
biocompatibility	O
of	O
the	O
3D	O
polycaprolactone	O
/	O
polyaniline	B:C0962453
composite	O
nanofibre	O
macrostructures	O
,	O
mouse	O
myoblasts	O
(	O
C2C12	O
cells	I:C0596995
)	O
were	O
cultured	O
as	O
model	O
cells	O
.	O

To	O
estimate	O
the	O
biocompatibility	O
of	O
the	O
3D	O
polycaprolactone	O
/	O
polyaniline	O
composite	B:C0009570
nanofibre	O
macrostructures	O
,	O
mouse	O
myoblasts	O
(	O
C2C12	O
cells	I:C0596995
)	O
were	O
cultured	O
as	O
model	O
cells	O
.	O

To	O
estimate	O
the	O
biocompatibility	O
of	O
the	O
3D	O
polycaprolactone	O
/	O
polyaniline	O
composite	O
nanofibre	O
macrostructures	B:C0678594
,	O
mouse	O
myoblasts	O
(	O
C2C12	O
cells	I:C0596995
)	O
were	O
cultured	O
as	O
model	O
cells	O
.	O

To	O
estimate	O
the	O
biocompatibility	O
of	O
the	O
3D	O
polycaprolactone	O
/	O
polyaniline	O
composite	O
nanofibre	O
macrostructures	O
,	O
mouse	B:C0025929
myoblasts	O
(	O
C2C12	O
cells	I:C0596995
)	O
were	O
cultured	O
as	O
model	O
cells	O
.	O

To	O
estimate	O
the	O
biocompatibility	O
of	O
the	O
3D	O
polycaprolactone	O
/	O
polyaniline	O
composite	O
nanofibre	O
macrostructures	O
,	O
mouse	O
myoblasts	B:C0596995
(	O
C2C12	O
cells	I:C0596995
)	O
were	O
cultured	O
as	O
model	O
cells	O
.	O

To	O
estimate	O
the	O
biocompatibility	O
of	O
the	O
3D	O
polycaprolactone	O
/	O
polyaniline	O
composite	O
nanofibre	O
macrostructures	O
,	O
mouse	O
myoblasts	O
(	O
C2C12	B:C0596995
cells	I:C0596995
)	O
were	O
cultured	O
as	O
model	O
cells	O
.	O

To	O
estimate	O
the	O
biocompatibility	O
of	O
the	O
3D	O
polycaprolactone	O
/	O
polyaniline	O
composite	O
nanofibre	O
macrostructures	O
,	O
mouse	O
myoblasts	O
(	O
C2C12	O
cells	I:C0596995
)	O
were	O
cultured	O
as	O
model	B:C2986594
cells	O
.	O

To	O
estimate	O
the	O
biocompatibility	O
of	O
the	O
3D	O
polycaprolactone	O
/	O
polyaniline	O
composite	O
nanofibre	O
macrostructures	O
,	O
mouse	O
myoblasts	O
(	O
C2C12	O
cells	I:C0596995
)	O
were	O
cultured	O
as	O
model	O
cells	B:C0007634
.	O

The	O
initial	O
responses	O
of	O
C2C12	B:C0596995
cells	I:C0596995
to	O
the	O
3D	O
polycaprolactone	O
/	O
polyaniline	O
composite	O
macrostructures	O
were	O
significantly	O
superior	O
to	O
those	O
to	O
pure	O
polycaprolactone	O
,	O
that	O
is	O
,	O
the	O
cells	O
exhibited	O
typical	O
myoblast	O
-	O
like	O
morphologies	O
with	O
obvious	O
pseudopodia	O
and	O
the	O
moderate	O
incorporation	O
(	O
less	O
than	O
2.0	O
wt	O
%	O
)	O
of	O
conductive	O
polyaniline	O
facilitated	O
cell	O
proliferation	I:C0596290
,	O
which	O
indicated	O
that	O
polyaniline	O
has	O
appreciable	O
cell	O
affinity	I:C3714634
.	O

The	O
initial	O
responses	O
of	O
C2C12	O
cells	I:C0596995
to	O
the	O
3D	B:C0450363
polycaprolactone	O
/	O
polyaniline	O
composite	O
macrostructures	O
were	O
significantly	O
superior	O
to	O
those	O
to	O
pure	O
polycaprolactone	O
,	O
that	O
is	O
,	O
the	O
cells	O
exhibited	O
typical	O
myoblast	O
-	O
like	O
morphologies	O
with	O
obvious	O
pseudopodia	O
and	O
the	O
moderate	O
incorporation	O
(	O
less	O
than	O
2.0	O
wt	O
%	O
)	O
of	O
conductive	O
polyaniline	O
facilitated	O
cell	O
proliferation	I:C0596290
,	O
which	O
indicated	O
that	O
polyaniline	O
has	O
appreciable	O
cell	O
affinity	I:C3714634
.	O

The	O
initial	O
responses	O
of	O
C2C12	O
cells	I:C0596995
to	O
the	O
3D	O
polycaprolactone	B:C0137734
/	O
polyaniline	O
composite	O
macrostructures	O
were	O
significantly	O
superior	O
to	O
those	O
to	O
pure	O
polycaprolactone	O
,	O
that	O
is	O
,	O
the	O
cells	O
exhibited	O
typical	O
myoblast	O
-	O
like	O
morphologies	O
with	O
obvious	O
pseudopodia	O
and	O
the	O
moderate	O
incorporation	O
(	O
less	O
than	O
2.0	O
wt	O
%	O
)	O
of	O
conductive	O
polyaniline	O
facilitated	O
cell	O
proliferation	I:C0596290
,	O
which	O
indicated	O
that	O
polyaniline	O
has	O
appreciable	O
cell	O
affinity	I:C3714634
.	O

The	O
initial	O
responses	O
of	O
C2C12	O
cells	I:C0596995
to	O
the	O
3D	O
polycaprolactone	O
/	O
polyaniline	B:C0962453
composite	O
macrostructures	O
were	O
significantly	O
superior	O
to	O
those	O
to	O
pure	O
polycaprolactone	O
,	O
that	O
is	O
,	O
the	O
cells	O
exhibited	O
typical	O
myoblast	O
-	O
like	O
morphologies	O
with	O
obvious	O
pseudopodia	O
and	O
the	O
moderate	O
incorporation	O
(	O
less	O
than	O
2.0	O
wt	O
%	O
)	O
of	O
conductive	O
polyaniline	O
facilitated	O
cell	O
proliferation	I:C0596290
,	O
which	O
indicated	O
that	O
polyaniline	O
has	O
appreciable	O
cell	O
affinity	I:C3714634
.	O

The	O
initial	O
responses	O
of	O
C2C12	O
cells	I:C0596995
to	O
the	O
3D	O
polycaprolactone	O
/	O
polyaniline	O
composite	B:C0009570
macrostructures	O
were	O
significantly	O
superior	O
to	O
those	O
to	O
pure	O
polycaprolactone	O
,	O
that	O
is	O
,	O
the	O
cells	O
exhibited	O
typical	O
myoblast	O
-	O
like	O
morphologies	O
with	O
obvious	O
pseudopodia	O
and	O
the	O
moderate	O
incorporation	O
(	O
less	O
than	O
2.0	O
wt	O
%	O
)	O
of	O
conductive	O
polyaniline	O
facilitated	O
cell	O
proliferation	I:C0596290
,	O
which	O
indicated	O
that	O
polyaniline	O
has	O
appreciable	O
cell	O
affinity	I:C3714634
.	O

The	O
initial	O
responses	O
of	O
C2C12	O
cells	I:C0596995
to	O
the	O
3D	O
polycaprolactone	O
/	O
polyaniline	O
composite	O
macrostructures	B:C0678594
were	O
significantly	O
superior	O
to	O
those	O
to	O
pure	O
polycaprolactone	O
,	O
that	O
is	O
,	O
the	O
cells	O
exhibited	O
typical	O
myoblast	O
-	O
like	O
morphologies	O
with	O
obvious	O
pseudopodia	O
and	O
the	O
moderate	O
incorporation	O
(	O
less	O
than	O
2.0	O
wt	O
%	O
)	O
of	O
conductive	O
polyaniline	O
facilitated	O
cell	O
proliferation	I:C0596290
,	O
which	O
indicated	O
that	O
polyaniline	O
has	O
appreciable	O
cell	O
affinity	I:C3714634
.	O

The	O
initial	O
responses	O
of	O
C2C12	O
cells	I:C0596995
to	O
the	O
3D	O
polycaprolactone	O
/	O
polyaniline	O
composite	O
macrostructures	O
were	O
significantly	O
superior	O
to	O
those	O
to	O
pure	O
polycaprolactone	B:C0137734
,	O
that	O
is	O
,	O
the	O
cells	O
exhibited	O
typical	O
myoblast	O
-	O
like	O
morphologies	O
with	O
obvious	O
pseudopodia	O
and	O
the	O
moderate	O
incorporation	O
(	O
less	O
than	O
2.0	O
wt	O
%	O
)	O
of	O
conductive	O
polyaniline	O
facilitated	O
cell	O
proliferation	I:C0596290
,	O
which	O
indicated	O
that	O
polyaniline	O
has	O
appreciable	O
cell	O
affinity	I:C3714634
.	O

The	O
initial	O
responses	O
of	O
C2C12	O
cells	I:C0596995
to	O
the	O
3D	O
polycaprolactone	O
/	O
polyaniline	O
composite	O
macrostructures	O
were	O
significantly	O
superior	O
to	O
those	O
to	O
pure	O
polycaprolactone	O
,	O
that	O
is	O
,	O
the	O
cells	B:C0007634
exhibited	O
typical	O
myoblast	O
-	O
like	O
morphologies	O
with	O
obvious	O
pseudopodia	O
and	O
the	O
moderate	O
incorporation	O
(	O
less	O
than	O
2.0	O
wt	O
%	O
)	O
of	O
conductive	O
polyaniline	O
facilitated	O
cell	O
proliferation	I:C0596290
,	O
which	O
indicated	O
that	O
polyaniline	O
has	O
appreciable	O
cell	O
affinity	I:C3714634
.	O

The	O
initial	O
responses	O
of	O
C2C12	O
cells	I:C0596995
to	O
the	O
3D	O
polycaprolactone	O
/	O
polyaniline	O
composite	O
macrostructures	O
were	O
significantly	O
superior	O
to	O
those	O
to	O
pure	O
polycaprolactone	O
,	O
that	O
is	O
,	O
the	O
cells	O
exhibited	O
typical	O
myoblast	O
-	O
like	O
morphologies	O
with	O
obvious	O
pseudopodia	B:C0033827
and	O
the	O
moderate	O
incorporation	O
(	O
less	O
than	O
2.0	O
wt	O
%	O
)	O
of	O
conductive	O
polyaniline	O
facilitated	O
cell	O
proliferation	I:C0596290
,	O
which	O
indicated	O
that	O
polyaniline	O
has	O
appreciable	O
cell	O
affinity	I:C3714634
.	O

The	O
initial	O
responses	O
of	O
C2C12	O
cells	I:C0596995
to	O
the	O
3D	O
polycaprolactone	O
/	O
polyaniline	O
composite	O
macrostructures	O
were	O
significantly	O
superior	O
to	O
those	O
to	O
pure	O
polycaprolactone	O
,	O
that	O
is	O
,	O
the	O
cells	O
exhibited	O
typical	O
myoblast	O
-	O
like	O
morphologies	O
with	O
obvious	O
pseudopodia	O
and	O
the	O
moderate	O
incorporation	O
(	O
less	O
than	O
2.0	O
wt	O
%	O
)	O
of	O
conductive	O
polyaniline	B:C0962453
facilitated	O
cell	O
proliferation	I:C0596290
,	O
which	O
indicated	O
that	O
polyaniline	O
has	O
appreciable	O
cell	O
affinity	I:C3714634
.	O

The	O
initial	O
responses	O
of	O
C2C12	O
cells	I:C0596995
to	O
the	O
3D	O
polycaprolactone	O
/	O
polyaniline	O
composite	O
macrostructures	O
were	O
significantly	O
superior	O
to	O
those	O
to	O
pure	O
polycaprolactone	O
,	O
that	O
is	O
,	O
the	O
cells	O
exhibited	O
typical	O
myoblast	O
-	O
like	O
morphologies	O
with	O
obvious	O
pseudopodia	O
and	O
the	O
moderate	O
incorporation	O
(	O
less	O
than	O
2.0	O
wt	O
%	O
)	O
of	O
conductive	O
polyaniline	O
facilitated	O
cell	B:C0596290
proliferation	I:C0596290
,	O
which	O
indicated	O
that	O
polyaniline	O
has	O
appreciable	O
cell	O
affinity	I:C3714634
.	O

The	O
initial	O
responses	O
of	O
C2C12	O
cells	I:C0596995
to	O
the	O
3D	O
polycaprolactone	O
/	O
polyaniline	O
composite	O
macrostructures	O
were	O
significantly	O
superior	O
to	O
those	O
to	O
pure	O
polycaprolactone	O
,	O
that	O
is	O
,	O
the	O
cells	O
exhibited	O
typical	O
myoblast	O
-	O
like	O
morphologies	O
with	O
obvious	O
pseudopodia	O
and	O
the	O
moderate	O
incorporation	O
(	O
less	O
than	O
2.0	O
wt	O
%	O
)	O
of	O
conductive	O
polyaniline	O
facilitated	O
cell	O
proliferation	I:C0596290
,	O
which	O
indicated	O
that	O
polyaniline	B:C0962453
has	O
appreciable	O
cell	O
affinity	I:C3714634
.	O

The	O
initial	O
responses	O
of	O
C2C12	O
cells	I:C0596995
to	O
the	O
3D	O
polycaprolactone	O
/	O
polyaniline	O
composite	O
macrostructures	O
were	O
significantly	O
superior	O
to	O
those	O
to	O
pure	O
polycaprolactone	O
,	O
that	O
is	O
,	O
the	O
cells	O
exhibited	O
typical	O
myoblast	O
-	O
like	O
morphologies	O
with	O
obvious	O
pseudopodia	O
and	O
the	O
moderate	O
incorporation	O
(	O
less	O
than	O
2.0	O
wt	O
%	O
)	O
of	O
conductive	O
polyaniline	O
facilitated	O
cell	O
proliferation	I:C0596290
,	O
which	O
indicated	O
that	O
polyaniline	O
has	O
appreciable	O
cell	B:C3714634
affinity	I:C3714634
.	O

Moreover	O
,	O
the	O
addition	O
of	O
conductive	O
polyaniline	B:C0962453
to	O
the	O
3D	O
composite	O
nanofibre	O
macrostructures	O
considerably	O
enhanced	O
myoblast	O
differentiation	I:C1159966
and	O
myotube	O
maturation	I:C2265916
.	O

Moreover	O
,	O
the	O
addition	O
of	O
conductive	O
polyaniline	O
to	O
the	O
3D	B:C0450363
composite	O
nanofibre	O
macrostructures	O
considerably	O
enhanced	O
myoblast	O
differentiation	I:C1159966
and	O
myotube	O
maturation	I:C2265916
.	O

Moreover	O
,	O
the	O
addition	O
of	O
conductive	O
polyaniline	O
to	O
the	O
3D	O
composite	B:C0009570
nanofibre	O
macrostructures	O
considerably	O
enhanced	O
myoblast	O
differentiation	I:C1159966
and	O
myotube	O
maturation	I:C2265916
.	O

Moreover	O
,	O
the	O
addition	O
of	O
conductive	O
polyaniline	O
to	O
the	O
3D	O
composite	O
nanofibre	O
macrostructures	B:C0678594
considerably	O
enhanced	O
myoblast	O
differentiation	I:C1159966
and	O
myotube	O
maturation	I:C2265916
.	O

Moreover	O
,	O
the	O
addition	O
of	O
conductive	O
polyaniline	O
to	O
the	O
3D	O
composite	O
nanofibre	O
macrostructures	O
considerably	O
enhanced	O
myoblast	B:C1159966
differentiation	I:C1159966
and	O
myotube	O
maturation	I:C2265916
.	O

Moreover	O
,	O
the	O
addition	O
of	O
conductive	O
polyaniline	O
to	O
the	O
3D	O
composite	O
nanofibre	O
macrostructures	O
considerably	O
enhanced	O
myoblast	O
differentiation	I:C1159966
and	O
myotube	B:C2265916
maturation	I:C2265916
.	O

These	O
results	O
suggest	O
that	O
electrospun	O
3D	B:C0450363
polycaprolactone	O
/	O
polyaniline	O
composite	O
nanofibre	O
macrostructures	O
would	O
have	O
promising	O
applications	O
in	O
tissue	O
engineering	I:C0596171
.	O

These	O
results	O
suggest	O
that	O
electrospun	O
3D	O
polycaprolactone	B:C0137734
/	O
polyaniline	O
composite	O
nanofibre	O
macrostructures	O
would	O
have	O
promising	O
applications	O
in	O
tissue	O
engineering	I:C0596171
.	O

These	O
results	O
suggest	O
that	O
electrospun	O
3D	O
polycaprolactone	O
/	O
polyaniline	B:C0962453
composite	O
nanofibre	O
macrostructures	O
would	O
have	O
promising	O
applications	O
in	O
tissue	O
engineering	I:C0596171
.	O

These	O
results	O
suggest	O
that	O
electrospun	O
3D	O
polycaprolactone	O
/	O
polyaniline	O
composite	B:C0009570
nanofibre	O
macrostructures	O
would	O
have	O
promising	O
applications	O
in	O
tissue	O
engineering	I:C0596171
.	O

These	O
results	O
suggest	O
that	O
electrospun	O
3D	O
polycaprolactone	O
/	O
polyaniline	O
composite	O
nanofibre	O
macrostructures	B:C0678594
would	O
have	O
promising	O
applications	O
in	O
tissue	O
engineering	I:C0596171
.	O

These	O
results	O
suggest	O
that	O
electrospun	O
3D	O
polycaprolactone	O
/	O
polyaniline	O
composite	O
nanofibre	O
macrostructures	O
would	O
have	O
promising	O
applications	O
in	O
tissue	B:C0596171
engineering	I:C0596171
.	O

